Skip to main content
TipRanks
Go Ultimate75% OFF

Covestro (1COVN) Q3 2025 Earnings Report

0 Followers

MX:1COVN Q3 2025 EPS Results

Actual EPS
-MXN 5.30
Consensus EPS
-MXN 6.19
Beat/Miss
Beat by +MXN 0.89
One Year Ago EPS
MXN 3.60

MX:1COVN Q3 2025 Revenue Results

Actual Revenue
MXN 67.19B
Expected Revenue
MXN 67.44B
Beat/Miss
Missed by -MXN 254.26M
YoY Revenue Growth
-11.99%

Earnings Announcement Details

Quarter
Q3 2025
Date
10/30/2025
Time
Before Open
Conference Call
Thursday, October 30, 2025
MX:1COVN Upcoming Earnings

Covestro's next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q3 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2025 Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 30, 2025|% Change Since:-0.67%|
Earnings Call Sentiment|Negative

The quarter shows clear operational and market challenges: a sizable sales decline (-12% YoY), EBITDA pressures (-15.7% YoY) and a material guidance downgrade to EUR 700–800 million for FY2025 driven by pricing, FX and the Dormagen incident (estimated up to EUR 150m). Offsets include successful cost-savings that supported Q3 EBITDA, a positive Q3 free operating cash flow (EUR 111m), a EUR 75m insurance reimbursement, strategic acquisitions to expand aliphatics capacity, and maintained credit metrics with Moody's confirming an investment-grade rating. Overall, the negative financial trends and the significant guidance reduction outweigh the mitigating positives.

Company Guidance

Covestro narrowed its FY2025 guidance, now targeting EBITDA of EUR 700–800 million (midpoint EUR 750m, down from a Feb midpoint of EUR 1.3bn and a July midpoint of EUR 900m), free operating cash flow of -EUR 400 to -EUR 200 million (9M FOCF -EUR 370m; Q3 FOCF +EUR 111m), and sales around EUR 13.0 billion (Q3 sales EUR 3.2bn); CapEx remains guided at EUR 700–800m (9M CapEx EUR 556m), ROCE above WACC is forecast at -9 to -8 percentage points, greenhouse gas emissions are narrowed to 4.2–4.4 million tonnes, total net debt rose EUR 292m vs end‑2024 with a net‑debt/EBITDA of 3.8x (4‑quarter rolling EBITDA EUR 0.8bn), and the Dormagen incident is expected to burden FY EBITDA by up to EUR 150m (EUR 75m insurance payment received, EUR 25m deductible, coverage expected above EUR 100m); management also flagged pulling forward low‑ to mid‑double‑digit million euro restructuring costs into 2025 as a mitigation measure.

  • Strategic Acquisitions and Capacity ExpansionCompleted purchase of Pontacol in Q3 2025 and signed agreement to acquire 2 HDI derivative production facilities from Vencorex (Rayong, Thailand and Freeport, U.S.) expected to close in Q1 2026. Deal expands aliphatics footprint in U.S. and APAC, expected to add a low double-digit million euro EBITDA and deliver synergies of up to high double-digit million euros within five years.
  • EBITDA Resilience and Cost Savings DeliveryQ3 2025 EBITDA of EUR 242 million (towards the upper end of the quarter guidance range) despite market headwinds; year-over-year EBITDA decline limited by successful short-term contingency savings and longer-term structural savings. Solutions & Specialties EBITDA margin increased to 12%.
  • Positive Q3 Free Operating Cash Flow and Insurance SupportQ3 free operating cash flow was positive EUR 111 million. Performance Materials benefited from a EUR 75 million insurance reimbursement booked in Q3, which supported segment EBITDA and mitigated some operational losses related to the Dormagen incident.
  • Maintained Capital Discipline and Credit OutlookFull-year CapEx guidance maintained at EUR 700–800 million; net debt-to-EBITDA ratio reported at 3.8x based on rolling EBITDA. Moody's confirmed an investment-grade rating with a stable outlook in April, supporting financial credibility.
  • Progress on XRG TransactionMost pre-closing merger control approvals completed (Vietnam, Indonesia to be addressed post-closing as required). German FDI clearance and EU Foreign Subsidies Regulation (Phase 2) remain in final stages; management remains on track to close before the December 2 long-stop date.
  • Regional and Industry OffsetsVolume growth in APAC and North America partially offset declines in Europe. Automotive showed a low single-digit increase year-over-year (benefitting from a low Q3 2024 baseline), and the electric vehicle segment continues strong momentum with a projected 25.7% growth rate.

MX:1COVN Earnings History

MX:1COVN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 04, 20272026 (Q4)―--41.53――
Nov 03, 20262026 (Q3)―--5.3―
Jul 31, 20262026 (Q2)―12.29-6.57287.10% (+18.86)
May 05, 20262026 (Q1)―--18.01―
Feb 26, 20262025 (Q4)-2.97-41.53-21.61-92.16% (-19.92)
Oct 30, 20252025 (Q3)-6.19-5.303.6-247.06% (-8.90)
Jul 31, 20252025 (Q2)-3.03-6.57-8.0518.42% (+1.48)
May 06, 20252025 (Q1)-4.49-18.01-4.03-347.37% (-13.98)
Feb 26, 20252024 (Q4)―-21.61-21.19-2.00% (-0.42)
Oct 29, 20242024 (Q3)-2.373.60-3.39206.25% (+6.99)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed